On May 28th, the U.S. Food and Drug Administration (FDA) approved cariprazine for the treatment of depressive episodes in adults...
Read More
Cariprazine, a medicine approved by the FDA in 2015 for the treatment of manic episodes in bipolar I disorder ,...
Read More
A multi-decade study focusing on children of parents diagnosed with bipolar disorder quantifies the risk—24.5%—that they themselves will develop bipolar...
Read More
Researchers have taken an important step toward understanding the relationship between two of the most serious psychiatric disorders, schizophrenia, and...
Read More
In the January issue of the journal Neuropsychopharmacology , Foundation-supported scientists report that they have stopped manic-like behavior in mice...
Read More